Circulation Journal
Reviews
Contemporary Medical Management of Systolic Heart Failure
Ajith P. NairTendoh TimohValentin Fuster
Author information
JOURNALS FREE ACCESS

Volume 76 (2012) Issue 2 Pages 268-277

Details
Download PDF (306K) Contact us
Abstract

Pharmacological therapy of systolic left ventricular dysfunction has evolved over the past 3 decades. Current therapy is focused primarily on the regulation of the renin-angiotensin-aldosterone axis and sympathetic nervous system. Additional targets of pharmacotherapy include vasoconstriction, impaired nitric oxide metabolism, inflammation and improving myocardial function. As therapies in chronic systolic heart failure have evolved beyond diuretics and digoxin, so too has mortality improved. Future directions in the management of heart failure include cell-based and genetic therapy, and further refinement of current therapy through genetics. (Circ J 2012; 76: 268-277)

Information related to the author
© 2012 THE JAPANESE CIRCULATION SOCIETY
Previous article Next article
feedback
Top